The British Asbestos Newsletter is a quarterly publication which is distributed to victim support groups, public bodies, lawyers, solicitors, barristers, researchers, doctors, academics and environmentalists in over thirty countries. Initially the focus of our articles was on asbestos-related news in Britain but latterly European, Australian and international events have been covered. The deciding factor is that all stories contribute something towards the understanding of asbestos-related topics in differring areas: legal, medical, historic, economic, corporate, sociological, etc.

Tumors of the mesothelium can be either benign (non-cancerous) or malignant (cancerous). Since malignant mesothelioma is much more common than benign mesothelioma it is often simply called mesothelioma. Characteristics of a malignant tumor are that it has the ability to spread to other parts of the body, making it much more dangerous.

David M. Jablons, MD - Cardiothoracic Surgery. Dr. Jablons is certified by the American Board of Surgery and American Board of Thoracic Surgery. His special interest is in molecular biology of lung cancer and he is a leading expert in surgical therapy for malignant pleural mesothelioma.

Mesothelioma and Asbestos Exposure Lung Disease information. Provided by Mesothelioma Lawyers handling lawsuits and legal claims for victims against Asbestos manufacturers. Mesothelioma settlements, litigation, for asbestos injuries.

Housed within one of the nation's top biomedical research universities, the UCSF Comprehensive Cancer Center brings together hundreds of researchers and clinicians dedicated to four fundamental pursuits: basic science research into the causes and events of cancer's progression; clinical research to translate new knowledge into viable treatments; sensitive, state-of-the-art patient care; and population research to understand the determinants of cancer and to develop effective means of prevention, early detection, and quality-of-life improvement for those living with a cancer diagnosis.

Clinical trials are lung cancer research studies to evaluate ways to treat cancer are an option for many lung cancer patients. In some studies, all patients receive the new treatment. In others, doctors compare different therapies by giving the new treatment to one group of lung cancer patients and the usual (standard) therapy to another group. Through research, doctors are exploring new and possibly more effective ways to treat lung cancer.

The National Cancer Institute states that: "Malignant mesothelioma, a rare form of cancer, is a disease in which cancer (malignant) cells are found in the sac lining the chest (the pleura), the lining of the abdominal cavity (the peritoneum) or the lining around the heart (the pericardium)." Most people with malignant mesothelioma have worked on jobs where they breathed asbestos. Others have been exposed to asbestos in a household environment, often without knowing it. An exposure of as little as one or two months can result in mesothelioma 30 or 40 years later.

The UAB Comprehensive Cancer Center can provide you with personalized, expert cancer diagnosis and treatment. A caring and devoted team of researchers and physicians are working together to gain the latest molecular insights into cancer and bring the most innovative therapies to patients.

Mesothelioma Clinical Trials. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research.

General Information, Cellular Classification, Stage Information, Treatment Option Overview, Localized Malignant Mesothelioma (Stage I), Advanced Malignant Mesothelioma (Stages II, III, and IV), Recurrent Malignant Mesothelioma. Prognosis in this disease is difficult to assess consistently because there is great variability in the time before diagnosis and the rate of disease progression.